WASHINGTON, D.C.— Today, the House Energy and Commerce Committee passed legislation introduced by Rep. Susan Brooks (R-IN) and Rep. Joe Kennedy III (D-MA), H.R. 4641, to establish a task force comprised of patients, medical providers, hospitals, state medical boards, pain advocacy groups and federal agencies involved. The task force would be responsible for reviewing and updating best practices for prescribers of pain medication. Today, the House Energy and Commerce Committee considered a dozen proposals designed to address the heroin and opioid crisis. These proposals will move on to be considered by the House of Representatives in the coming weeks.
“We lose 78 Americans each day to opioid overdose,” Brooks said. “We have to act now to stem the tide of opioid abuse in this country, and it starts with giving prescribers, law enforcement, treatment professionals and communities the tools they need to prevent opioid abuse, treat substance abuse and addiction, and prevent illegal drugs from being bought and sold. I’m pleased that the House Energy and Commerce Committee passed a dozen proposals today to directly address this crisis, and look forward to swift consideration of these proposals by the full House.”
Brooks has joined her colleagues in leading efforts to combat the heroin and opioid abuse epidemic. A complete list of the bills considered by the Energy and Commerce Committee markup today is available here. Last week, the Health Subcommittee passed H.R. 4641, and Brooks made an opening statement which is available here. More information about H.R. 4641, legislation introduced by Reps. Brooks and Kennedy to provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, is available hereRead More
We are all aware of the serious opioid misuse, abuse, diversion and overdose issue in our country and the devastating effect it is having on communities across the United States. Consider this alarming statistic – overdoses (>50,000) have now surpassed car accidents as the number one cause of injury-related deaths nationwide.
Less familiar to the public and to policymakers are the millions of Americans suffering from debilitating chronic pain; however, the statistics are just as alarming. The Institute of Medicine (IOM) has called chronic pain a public health problem of epidemic proportions. According to the IOM’s Relieving Pain in America report, 1 in 3 Americans suffer from chronic pain; 100 million American suffer from back pain, headaches and arthritis; chronic pain is the number one cause of adult disability and it costs the United States economy more than $600 billion in direct healthcare costs and lost productivity every year.
The opioid epidemic has appropriately caught the attention of the media, policymakers and the public; but unfortunately, we still have a lot of work to do to raise awareness about the chronic pain crisis in America. As policymakers and healthcare professionals in Washington, DC and across the country grapple with how to address pain management and alternatives to opioid therapies, it is critical to address chronic pain as well.
Reducing overreliance on opioids for both acute and chronic pain will help reduce the negative consequences of abuse and diversion overall. I believe a balanced approach to manage pain – providing structured well-thought out policies that focus on interdisciplinary management that preserves access to the full range of medical options with appropriate screening and educational tools in place – is the ideal means by which to reform and revitalize the treatment of chronic pain and reduce opioid prescriptions overall.
As a board-certified, practicing pain physician here in Washington, D.C., I recently testified before the U.S. House of Representatives’ Bipartisan Task Force to Combat the Heroin Epidemic. I spoke about caring for patients every day who suffer from severe and debilitating chronic pain, and how every treatment solution should be different and individualized to the needs of that patient.
While opioids can and should be used as one form of pain management, there are many alternative solutions that should be promoted and explored further, including medical devices. It is important to note that there are numerous FDA-approved, non‐pharmacological, evidence‐based, cost-effective products currently on the market that are often overlooked. Examples of technology that help patients manage chronic pain include spinal cord stimulation, radiofrequency ablation, and implantable drug pumps.
The health care system needs to better understand which treatments are currently available to treat pain, whether or not they have strong evidence for efficacy, and the positive, long‐term impact they have on cost of care and outcomes. Opioids may continue to play a role in helping certain patients manage both acute and chronic pain, but learning about and employing additional treatment options including medical devices, physical therapy, acupuncture and other alternatives can provide patients with the comprehensive care they need – and possibly reduce the risk of opioid misuse, abuse and overdose overall.
The House Energy & Commerce Committee will mark up several pieces of opioid legislation this week, including HR 4641 sponsored by Representatives Susan Brooks and Joseph Kennedy. This legislation takes steps to address the challenges associated with chronic pain care, promote best practices and encourage adoption of alternative therapies – including medical technologies – to replace or to augment opioids. Substance abuse disorders and chronic pain are interrelated public health crises that must be addressed simultaneously and with equality, one without the other is tantamount to worsening each individual crisis. Passage of the Brooks Kennedy Pain Best Practices bill is an important advancement in addressing these two public health crises.
Desai, is board certified in Pain Medicine and Physical Medicine & Rehabilitation and President of the International Spine, Pain & Performance Center in Washington, D.C. He is an Instructor at The George Washington University School of Medicine and Health Sciences. Dr. Desai is also the former Director, Pain Medicine & Non-Operative Spine Services at The George Washington University/Medical Faculty Associates.Read More
WASHINGTON, DC – The Subcommittee on Health, chaired by Rep. Joseph Pitts (R-PA), has announced it will markup 12 bills on Wednesday, April 20, 2016, at 1:30 p.m. in room 2322 of the Rayburn House Office Building. A number of these bills help address the opioid and drug abuse crisis facing our nation. The markup was first announced on Friday.
The bills being considered are:
H.R. , Examining Opioid Treatment Infrastructure Act of 2016 – Authored by Rep. Bill Foster (D-IL) and Rep. Frank Pallone, Jr. (D-NJ), this legislation would require the Comptroller General of the United States to issue a report to Congress on substance abuse treatment availability and infrastructure needs throughout the United States. This report shall include an evaluation of various substance abuse treatment settings including inpatient, outpatient, and detoxification programs.
H.R. , the Opioid Use Disorder Treatment Expansion and Modernization Act – Authored by committee members Rep. Larry Bucshon, M.D. (R-IN) and Rep. Paul Tonko (D-NY), this legislation would amend the Controlled Substances Act to expand access to medication-assisted treatment, while ensuring that patients receive the full array of quality evidence-based services and minimizing the potential for drug diversion.
H.R. 1818, the Veteran Emergency Medical Technician Support Act of 2015 – Authored by committee member Rep. Adam Kinzinger (R-IL), this legislation (which passed the House last Congress) would create a demonstration program to streamline emergency medical technician state requirements and procedures for veterans who have already completed military emergency medical technician training.
H.R. 3250, the DXM Abuse Prevention Act of 2015 – Authored by committee member Rep. Bill Johnson (R-OH), this legislation would prohibit the sale of a drug containing dextromethorphan (DXM) unless the individual has a prescription or is actively enrolled in the military and place restrictions on distribution of bulk DXM.
H.R. 3680, the Co-Prescribing to Reduce Overdoses Act of 2015 – Authored by committee member Rep. John Sarbanes (D-MD), this legislation would create a grant program for co- prescribing of opioid reversal drugs for patients who are at a high risk of overdose.
H.R. 3691, the Improving Treatment for Pregnant and Postpartum Women Act of 2015 – Authored by committee member Rep. Ben Lujan (D-NM), this legislation would reauthorize a residential treatment program that currently provides numerous services to aide pregnant women or those with young children facing substance abuse.
H.R. 4586, Lali’s Law – Authored by Rep. Bob Dold (R-IL) and Rep. Katherine Clark (D-MA), this legislation would amend the Public Health Service Act to authorize grants to states for developing standing orders for naloxone prescriptions and educating health care professionals regarding the dispensing of opioid overdose reversal medication without person-specific prescriptions.
H.R. 4599, the Reducing Unused Medications Act of 2016 – Authored by Rep. Katherine Clark (D-MA) and Rep. Steve Stivers (R-OH), this legislation would amend the Controlled Substances Act (CSA) to clarify when a prescription for a drug listed on Schedule II of the CSA may be partially filled.
H.R. 4641, to provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes – Authored by committee member Rep. Susan Brooks (R-IN), this legislation would establish an inter-agency task force to review, modify, and update best practices for pain management and how pain medication is prescribed.
H.R. 4969, the John Thomas Decker Act – Authored by Rep. Pat Meehan (R-PA), Rep. Ron Kind (D-WI), and Rep. Marc Veasey (D-TX), this legislation would amend the Public Health Service Act to direct the CDC to study what information and resources are available to youth athletes and their families regarding the dangers of opioid use and abuse, non-opioid treatment options, and how to seek addiction treatment. The CDC would then be required to report its findings and work with stakeholders to disseminate resources to students, parents, and those involved in treating a sports related injury
H.R. 4976, the Opioid Review Modernization Act – Authored by Rep. Sean Maloney (D-NY) and committee member Rep. Leonard Lance (R-NJ), this legislation would require the FDA to work closely with expert advisory committees before making critical product approval and labeling decisions, and to make recommendations regarding education programs for prescribers of extended-release and long-acting opioids.
H.R. 4978, the Nurturing and Supporting Healthy Babies Act – Authored by Rep. Evan Jenkins (R-WV) and Rep. Cheri Bustos (D-IL), this legislation would require the Comptroller General of the United States to issue a report one year after enactment on neonatal abstinence syndrome (NAS).
“The Health Subcommittee this week will mark up a series of bills to address the rampant opioid epidemic in America today. We cannot continue to lose our sons, daughters, nieces, and nephews to this preventable outbreak which takes a life every twelve minutes,” said Chairman Pitts. “Over the past year we’ve held numerous hearings to gather testimony about how opioid abuse is treated and how victims can be better helped; now we are ready to put that knowledge into action.”
Electronic copies of the bills can be found on the Energy and Commerce Committee’s website here. A background memorandum, amendments, and votes will be available at the same link as they are posted.Read More
Today, more people are dying of drug overdoses than car accidents. And you, our local officials, are seeing the statistic become reality in your communities and states. But where does it begin?
Eighty percent of heroin addictions start with a legal pain medication.
I believe that the key to stemming the tide of heroin and opioid abuse, and drug overdose deaths, is to address the issue of over-prescribing pain medication in this country by increasing education and awareness among prescribers and medical providers about the problem. However, I know we can’t do it alone, and as a federal legislator, I know enough to know when I’m not the expert.
Legislation I’ve introduced would bring together every stakeholder involved in this debate, from former addicts and current chronic pain patients, to pharmacists and medical providers, and every federal agency involved in pain management or prescriptions, including the Department of Defense, to develop some guidelines that can be applied by every provider to eliminate unnecessary or excessive prescriptions. My legislation, H.R. 4641, would establish this task force, and require it to regularly review and update prescribing guidelines.
But this alone isn’t a silver bullet.
Millions of Americans are abusing prescription drugs every day, and still more are abusing illegal drugs like heroin. We must beef up our enforcement as a country and I believe we need to strengthen penalties for drug dealers. I also think we should support efforts to make overdose reversal drugs more widely available to first responders.
We must also change the way that we treat addiction and substance abuse. It is a disease and should be treated as such. There is no one treatment program that will work for every patient – and as legislators, it’s our responsibility to recognize and allow for a variety of effective treatments with proven results in combating the disease of addiction.
Big picture, we must consider the other ripple effects that this crisis has in our communities – and protect against diseases commonly caused by intravenous drug use like HIV and Hepatitis C – as well as better understand how to help babies who are born addicted and children who are victims of this epidemic because of their parent’s addiction.
ALEC has an enormous role to play in this fight. Local partners are on the front lines of this epidemic, and as a member of Congress, I look to my district for guidance and feedback when considering proposals and programs to be implemented nationally.
It is going to take all of us to turn the tide of the heroin and opioid epidemic, and I’m looking forward to discussing the crisis, my legislative proposal, and the Congressional action likely to take place. More importantly, I’m hoping to hear from you about what you are seeing in your communities, and how you think the federal government can support your local efforts effectively. Thank you for the invitation to talk about this important topic, and I look forward to our conversation on April 20th.Read More
WASHINGTON, DC – Today, Speaker Paul Ryan (R-WI) signed companion legislation, S. 2512, to a proposal introduced earlier this year by Representatives G. K. Butterfield (NC-01) and Susan Brooks (IN-05), H.R. 4400. This bipartisan bill adds Zika virus to the list of diseases included in the Tropical Disease Priority Review Voucher Program at the Food and Drug Administration (FDA). This legislation will be sent to the President’s desk to be signed into law. The Zika virus, which is transmitted to humans by mosquitoes and can be transmitted sexually, can infect pregnant women and result in birth defects, including microcephaly and neurological disorders in newborns. The virus also causes skin rashes, conjunctivitis, muscle and joint pain, and headaches in adults. This week the Centers for Disease Control and Prevention (CDC) indicated at least 30 U.S. states are at risk of Zika virus transmission this spring and summer.
“Our national defense and public health systems are underprepared to meet the challenges of an outbreak like Zika virus, and in fact, we know very little about the virus. Just two weeks ago, we uncovered the structure of the Zika virus thanks to a talented group of researchers at Purdue University. Understanding the structure of a biological threat is a key first step in developing a vaccine or treatment,” Brooks said. “With the passage of this proposal, we can rest assured that nothing will stand in the way of our best minds using the newly discovered structure to inform development, testing and ultimate distribution of a vaccine or therapy for Zika virus.”
The Priority Review Voucher Program was authorized by Congress in 2007 to incentivize the development of treatments, including vaccines and cures, for neglected tropical diseases. Under the program, a company that receives approval for a tropical disease treatment is eligible to receive a voucher that allows the company to receive priority review status for any future product. Products undergoing priority review are generally provided with an approval decision within six months.
“This proposal is a no-cost solution that doesn’t undermine the review process or the safety of a vaccine or therapy,” Brooks continued. “Although I’m pleased that Congress has acted in response to this outbreak, I’m hopeful that my proposal to incentivize cures and treatments for other dangerous and deadly diseases that pose threats to our public health and national security will be considered in the coming months. By acting now to implement proactive solutions, we can better prepare for the next outbreak or epidemic.”
In May 2015, Brazil reported its first case of Zika virus. There have been 346 confirmed cases of Zika virus in the continental United States according to the CDC, all associated with travel. Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases anticipates that initial trials for a Zika vaccine could start as early as September of this year, but that distribution of the vaccine is unlikely to occur before the beginning of 2018. The pandemic is so concerning that some governments are urging women to delay pregnancy altogether until a treatment or vaccine is created.
Speaker Paul Ryan (R-WI) signs S. 2512 in his office in the U.S. Capitol Building as Rep. Susan Brooks (R-IN) looks on.
This week, Congress acted to fight the threat of the Zika virus in the United States. Today, Rep. Susan Brooks (R-IN) joined Speaker Ryan as he signed bipartisan legislation to accelerate the development of a treatment—and ultimately a cure—for the virus. Rep. Brooks introduced the House version of this legislation.
Congress continues to work to ensure the administration has the tools it needs to combat this public health crisis.
U.S. Rep. Susan Brooks (R-IN) hosted a biodefense exercise on Monday in Fishers, Indiana, that simulated a smallpox outbreak to gauge response capabilities in the Hoosier State.
During the tabletop exercise, 35 local and state officials made a series of decisions about how to respond to a simulated small pox outbreak that started with a single case in Europe.
“I want to thank all of our attendees for their enthusiasm and insights during today’s exercise,” Brooks said. “The risks to Indiana and Indianapolis from a biological threat, like smallpox, are real. (Monday’s) exercise was an opportunity to test our instincts and protocols for an outbreak in a safe and risk-free environment. Hopefully the relationships and understanding we gained from this exercise will help us respond more effectively in the face of a real biological threat to Hoosiers.”
Brooks has led recent legislative efforts to develop vaccines and therapies for deadly diseases before outbreaks occur. She introduced the Strengthening Public Health and Response Act, H.R. 3299, last year, and cosponsored a bill in February that would add Zika virus to the FDA’s Tropical Disease Priority Review Voucher Program.
“I think what we learned (on Monday) is that there is no easy answer when it comes to effective and responsive biodefense, but with good preparation and widespread public awareness of the risks, we can protect our national security and public health,” Brooks said. “In Congress, I am focused on improving our national biodefense strategies and systems, including incentivizing vaccines and treatments for deadly and dangerous diseases that pose significant threats to our public health. Prioritizing efforts to protect our country from biological threats will provide the certainty and support our local partners need to effectively prepare for and respond to future outbreaks.”Read More
The House on Tuesday overwhelmingly approved a bill to offer incentives to companies seeking cures for the Zika virus amid Congress’s growing battle over funding for the epidemic.
The bipartisan legislation would add the Zika virus to a list of diseases that qualifies for a “priority review” voucher from the Food and Drug Administration (FDA). It passed the Senate last month.
"This is a significant incentive for private industry to invest the hundreds of millions of dollars and the many man hours it takes to produce a vaccine or treatment," Rep. Susan Brooks (R-Ind.), one of the bill's authors, said on the House floor.
The bill does not touch the federal funding fight over Zika, which has been bitterly partisan for weeks. It was approved by voice vote.
House Speaker Paul Ryan (R-Wis.) praised the FDA bill as a bipartisan effort to “aid the response” and "protect Americans" against Zika, as he and other GOP leaders remain staunchly opposed to adding more funding.
GOP leaders have for months resisted pressure from the Obama administration to approve his nearly $2 billion emergency funding request. Last week, federal health officials announced they would dip into its Ebola funding pool to shore up the response to Zika — a move previously dismissed by the administration.
Ryan did not rule out further action on Zika.
“We will continue to monitor the government’s response, and work to protect the American people,” he said in his statement.Read More
Indianapolis, Ind. — U.S. Senator Joe Donnelly and U.S. Representative Susan Brooks met with Indiana University School of Medicine doctors, professors, faculty and medical residents today in Indianapolis. Donnelly and Brooks learned more about the recent changes to how IU, the largest medical school in the nation, is educating and training medical students, residents, and current physicians on best prescribing practices, pain management, substance abuse, and treating addiction.
Senator Donnelly and Congresswoman Brooks at IU School of Medicine today. For HD versions, click here.
Donnelly said, “The opioid abuse and heroin use epidemics are devastating communities across our state, and it will take all of us – including doctors, medical students, and other prescribers – working together to address these public health crises. It is great to have IU School of Medicine as a partner in this effort and to hear directly from professors, current physicians, and medical residents about the updates and changes IU is making to its curriculum and training as we work to prevent opioid abuse and treat addiction.”
Brooks said, “IU School of Medicine is the largest medical school in the state of Indiana, and I applaud its work to prepare students, residents and medical professionals to meet the challenges of the opioid abuse epidemic that is raging in our homes, our communities, and our country. Eighty percent of heroin addictions begin with abuse of a legal opioid. Addressing the over-prescription of this type of pain medication is a critical piece of any response to the crisis, and prescribers and medical professionals are often the first line of defense.”
Jay L. Hess, M.D., Ph.D, dean of the IU School of Medicine and vice president for university clinical affairs for IU said, “The IU School of Medicine has long supported the education of medical students, residents, fellows and other providers across the state on this pressing public health issue. We recognize the ongoing needs for additional pain treatment specialists, addiction therapy specialists and treatment programs for our citizens. These important resources will require widespread support at the local, state and national level if we are to reach the desired goals for appropriate treatment and prevention within the Hoosier state.”
IU School of Medicine is engaged in an ongoing effort that includes their undergraduate, graduate, and continuing education programs. In addition, IU School of Medicine is also working with students in other health professional programs, such as nursing and pharmacy, to integrate the new efforts on pain management in the curriculum.
Donnelly and Brooks have continually worked together to address the opioid and heroin epidemics. In September 2015, they co-hosted a roundtable at IUPUI on the need for a collaborative response to the opioid abuse and heroin use epidemics, including the role medical students, physicians, and prescribers can play.
Last month, Donnelly helped the Senate pass bipartisan legislation designed to help address opioid abuse. This legislation includes provisions adopted and similar to bipartisan legislation that Donnelly reintroduced last year focused on developing best prescribing practices and raising public awareness, as well as a program to expand access to life-saving naloxone. The House of Representatives is expected to begin consideration of legislation later this month to address the crisis, including a proposal introduced by Brooks to establish a prescriber best practices inter-agency task force.Read More
FISHERS, Ind.— Today, Congresswoman Susan W. Brooks (R-IN) hosted a biodefense tabletop exercise simulating an European smallpox outbreak and exploring the implications of the outbreak on stateside response activities in Indiana. Over 35 attendees including representatives from local health departments, first responders, homeland security officials, healthcare professionals, and others, participated in today’s exercise. The simulation was led by Dr. Craig Vanderwagen, RADM, USPHS, the founding Assistant Secretary for Preparedness & Response at the Department of Health and Human Services responsible for preparing the United States for response and recovery from natural or manmade health disasters.
“I want to thank all of our attendees for their enthusiasm and insights during today’s exercise. The risks to Indiana and Indianapolis from a biological threat, like smallpox, are real. Today’s exercise was an opportunity to test our instincts and protocols for an outbreak in a safe and risk-free environment. Hopefully the relationships and understanding we gained from this exercise will help us respond more effectively in the face of a real biological threat to Hoosiers.”
During the exercise, participants were asked to make decisions about how to respond to a series of events, beginning with a single case of smallpox in Europe. Of all the threats to our national public health, smallpox is probably the greatest. It is highly infectious, even more so than Ebola, and has a high mortality rate. Although a vaccine exists, very few Americans born after 1980 have been immunized. In recent months, the threat of terrorist organizations, like ISIS, using biological weapons, like smallpox, has become a growing concern. As the events in the simulation unfolded, eventually leading to a worldwide outbreak of smallpox, participants were asked to choose the best course of action to protect the health and safety of Hoosiers. Fishers is the fourth community in the world to conduct this tabletop exercise.
“I think what we learned today is that there is no easy answer when it comes to effective and responsive biodefense, but with good preparation and widespread public awareness of the risks, we can protect our national security and public health. In Congress, I am focused on improving our national biodefense strategies and systems, including incentivizing vaccines and treatments for deadly and dangerous diseases that pose significant threats to our public health. Prioritizing efforts to protect our country from biological threats will provide the certainty and support our local partners need to effectively prepare for and respond to future outbreaks.”
Brooks has been leading efforts in Congress to act on the 33 recommendations presented last fall by the Blue Ribbon Study Panel on Biodefense. Last year, she introduced legislation to incentivize the development of vaccines and therapies for deadly and dangerous diseases before an outbreak occurs. H.R. 3299, the Strengthening Public Health Emergency Response Act, was co-sponsored by Representative Anna Eshoo (D-CA). Additionally, Brooks co-sponsored legislation with Rep. G.K. Butterfield (D-NC) that would add Zika virus to the FDA Tropical Disease Priority Review Voucher Program. H.R. 4400 was introduced on February 1, 2016.
Representatives from the following organizations participated in today’s exercise:
Biologics Modular (Brownsburg, IN)
City of Indianapolis Homeland Security
Community Health Network
Fishers Fire and Rescue
Hamilton County Emergency Management
Hamilton County Health Department
Indiana Department of Homeland Security
Indiana Poison Center
Indiana State Department of Health
Indiana University Health
Madison County Health Department
Marion County Public Health Department
Medxcel Facilities Management (Indianapolis, IN)
Richard L. Roudebush VA Medical Center
St. Francis Health
St. Vincent Health
1505 Longworth HOB
Washington, DC 20515
Congresswoman Susan Brooks represents the 5th District of Indiana, which spans eight diverse counties throughout the central part of the Hoosier State. As a new member of Congress, she currently serves on the Education and Workforce, Homeland Security and Ethics Committees. She is also the Chairwoman of the Subcommittee on Emergency Preparedness, Response and Communications.
Her strong background in both the public and private sectors includes experience as a proven difference maker in areas such as public safety, homeland security, counter-terrorism and economic development.
Before joining the House of Representatives, Susan served as Senior Vice President and General Counsel for Ivy Tech Community College. Collaborating with a wide network or stakeholders, she implemented workforce development strategies aiming to enhance job training and placement for thousands of Hoosier residents.
In 2001, President George W. Bush appointed Susan as U.S. Attorney for the Southern District of Indiana. Serving as the chief federal law enforcement officer for a majority of the Hoosier state, she received bi-partisan acclaim for efforts to battle mortgage fraud, gun violence, drug trafficking, gangs, child exploitation and identity theft.
Susan also earned recognition as Deputy Mayor of Indianapolis during the Steve Goldsmith administration, where she provided oversight on public safety operations and drove community dialogue on vital civic issues. Over her tenure, she managed police, fire and emergency response efforts while serving on boards related to criminal justice, community corrections, violence reduction and race relations.
Susan practiced law at the Indianapolis firm of Ice Miller and also served as a criminal defense attorney for Indianapolis based McClure, McClure and Kammen.
After receiving her undergraduate degree from Miami University of Ohio, Susan pursued a Juris Doctor (J.D.) from the Indiana University Robert H. McKinney School of Law. In May of 2013, Susan was awarded an honorary Doctor of Public Service degree from Marian University in Indianapolis. She resides in Carmel, Indiana with her husband David and they have two young adult children.
Retweeted by SusanWBrooks
May is Mental Health Awareness Month. Join Fishers, Indiana, and pledge to learn more about and raise awareness of mental health. One in five
It's Small Business Week! Small businesses help support our communities and help them grow. What #IN05 businesses will you be supporting this
Honored to be with so many Hamilton County, Indiana, law enforcement officers and their families to honor and remember fallen officers. I am
My thoughts and prayers are with the family of a dear friend, Fire Chief Keith Smith, who passed away this afternoon. I had the honor of working
Spent this morning visiting students at Sycamore School talking about their recent visit to D.C. and answering their questions. Great to be with